Telesis Bio, Inc. (TBIO) Covered Calls
There are no covered calls available for Telesis Bio, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.
| Top 10 Open Interest For Oct 18 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SLV covered calls | 1. | RLAY covered calls | |
| 2. | IWM covered calls | 7. | GLD covered calls | 2. | LUNR covered calls | |
| 3. | SPY covered calls | 8. | TLT covered calls | 3. | MARA covered calls | |
| 4. | QQQ covered calls | 9. | EEM covered calls | 4. | CPRI covered calls | |
| 5. | HYG covered calls | 10. | AAPL covered calls | 5. | MBLY covered calls | |
Want more examples? TBI Covered Calls | TBNK Covered Calls
